Option chain shows key data for Cogstate's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cogstate.

Cogstate (OTC:COGZF) Stock, Option Chain

Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

Cannabis

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Penny Stocks

Commodities

Management

Events

Small Business

Markets

Tech

General

CTGO

RIII

WRIV

MEDXF

TSXV:MDP

ACCMF

PTQQF

TSXV:PTQ

NEXCF

CSE:NTAR

RHNMF

SBVCF

BBKCF

CSE:BIGG

APGMF

FNNZF

CSE:CALI

COGZF

DYFSF

TSX:DYA

THBRF

TSXV:TBRD

BCEKF

TSXV:BCM

BLSTF

RVLGF

TSXV:RVG

AOTVF

TSX:AOT

WINKF

TSXV:WIN

FRERF

TSXV:FRE

GLATF

TSX:GLO

RDGMF

TSXV:RDG

UGDIF

TSXV:UGD

CXBMF

TSX:CXB

BBBXF

TSXV:BBB

SILEF

TSX:ELEF

TRUIF

TSXV:TRU

FVANF

TSXV:FVAN

NUPMF

TSXV:NUAG

GLDRF

CSE:ITKO

AVGDF

TSXV:AVG

FFMGF

TSX:FF

IRVRF

CSE:IRV

BNCHF

TSXV:BNCH

CGOL

TSXV:C

GGGOF

TSXV:GG

GTAGF

TSXV:GOG

SSVRF

CSE:SSVR

AUXXF

TSXV:AUAU

JOSMF

TSX:JOSE

FLMMF

TSXV:FIL

TLRS

TSXV:TBR

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

As we approach the end of what has been an extraordinary year, companies and investors alike are turning their attention to 2021—if they haven’t already. 

46 Emerging Technology And Mining Companies Giving 2020 Investor Recaps This Month

Insider Trades

Global

Cogstate Acquires 100% Holding of Axon Sports

Cogstate Ltd

CogState (COGZF) today announced that it will acquire the remaining 50% stake in Axon Sports, resulting in Axon Sports becoming a 100% owned subsidiary.

Axon Sports provides online cognitive assessment to assist in evaluating and managing sports-related concussions. For CogState, the management of concussion in sport is a fast growing market, providing enormous opportunity for growth of revenue and profitability in the short term.

The 100% control of Axon Sports will allow CogState to utilise the Axon Sports online testing and associated materials to pursue the sports concussion markets outside North America.

Importantly, 100% control of Axon Sports means that CogState is in a position to take full advantage of current opportunities being discussed with large pharmaceutical companies with the aim of making CogState technology available to clinicians as a low cost, non -invasive, screening tool that could be provided within a clinician‟s surgery, in numerous indications, including sports concussions.

CogState will acquire the 50% stake for 7,461,831 CogState Ltd fully paid ordinary shares at a notional price of $0.17 per share.

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the cessation of over 1.2 million options due to failure to meet condition...

Cogstate Ltd Options Cease as Conditions Unmet

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the issuance of 3,756,569 new performance rights as part of their employee...

Cogstate Ltd Issues New Employee Incentive Securities

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the cessation of 31,914 performance rights due to unmet conditions as of O...

Cogstate Ltd Reports Lapse of Performance Rights

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a new on-market share buyback program, allowing the repurchase of up to 10...

Cogstate Ltd Launches New Share Buyback Program

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd, a leader in neuroscience technology, continues to enhance brain health assessments thro...

Cogstate Ltd Expands Brain Health Assessment Innovations

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nerv...

Cogstate Partners with Medidata for Strategic Growth

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd announced a change in the director's interest, with Bradley O'Connor receiving 920,251 p...

Cogstate Director Receives New Performance Rights

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the issuance of 1,333,973 performance rights as part of an employee incent...

Cogstate Ltd Issues New Performance Rights

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced an update on its ongoing share buy-back program, revealing that it purchas...

Cogstate Ltd Updates on Share Buy-Back Program

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a daily update on its share buy-back program, with a total of 64,532 ordin...

Cogstate Ltd Updates on Share Buy-back Program

Press Releases

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Cogstate

Comments

Cogstate

Cogstate (COGZF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga